Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ravulizumab LA by Alexion Pharmaceuticals for IgA Nephropathy (Berger's Disease): Likelihood of Approval
Ravulizumab LA is under clinical development by Alexion Pharmaceuticals and currently in Phase III for IgA Nephropathy (Berger's Disease). According...